ADMP logo

Adamis Pharmaceuticals (ADMP) Accounts Payable

Annual Accounts Payable

$7.94 M
+$4.18 M+111.44%

December 31, 2022

Summary

Performance

1-Year Change

+111.44%

3-Year Change

+85.99%

5-Year Change

+171.92%

15-Year Change

+171.92%

ADMP Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$7.94 M
ADMP annual accounts payable is currently at an all-time high

3-Year Low

$3.75 M
ADMP annual accounts payable is currently +111.44% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
ADMP previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
ADMP next annual earnings announcement has not yet been scheduled

OtherADMPbalance sheetmetrics:

Annual Accounts Receivable

$1.05 M
ADMP annual accounts receivable is $1.05 million

Annual Total Liabilities

$11.74 M
ADMP annual total liabilities is $11.74 million

Annual Total Assets

$10.93 M
ADMP annual total assets is $10.93 million

Annual Current Assets

$9.27 M
ADMP annual total current assets is $9.27 million

Quarterly Accounts Payable

$11.37 M
+$1.58 M+16.20%

June 30, 2023

Summary

Performance

3-Month Change

+16.2%

1-Year Change

+151.64%

3-Year Change

+166.5%

5-Year Change

+120.11%

ADMP Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$11.37 M
ADMP quarterly accounts payable is currently at an all-time high

3-Year Low

$3.75 M
ADMP quarterly accounts payable is currently +202.77% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
ADMP previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
ADMP next earnings announcement has not yet been scheduled

OtherADMPbalance sheetmetrics:

Quarterly Accounts Receivable

$0.00
ADMP quarterly accounts receivable is $0.00

Quarterly Total Liabilities

$16.57 M
ADMP quarterly total liabilities is $16.57 million

Quarterly Total Assets

$4.75 M
ADMP quarterly total assets is $4.75 million

Quarterly Current Assets

$3.45 M
ADMP quarterly total current assets is $3.45 million

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

ADMP Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+111.4%+151.6%
3 y3 years+86.0%+166.5%
5 y5 years+171.9%+120.1%

ADMP Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-52.7%at high-67.0%
5 y5-yearat high-77.6%at high-84.3%
alltimeall timeat high-100.0%at high-100.0%

Adamis Pharmaceuticals Accounts Payable History

DateAnnualQuarterly
Jun 2023
-
$11.37 M(+16.2%)
Mar 2023
-
$9.78 M(+23.2%)
Dec 2022
$7.94 M(+111.4%)
$7.94 M(+49.8%)
Sep 2022
-
$5.30 M(+17.3%)
Jun 2022
-
$4.52 M(-7.7%)
Mar 2022
-
$4.89 M(+30.3%)
Dec 2021
$3.75 M(+110.9%)
$3.75 M(+53.0%)
Sep 2021
-
$2.45 M(-18.5%)
Jun 2021
-
$3.01 M(-25.4%)
Mar 2021
-
$4.04 M(+126.7%)
Dec 2020
$1.78 M(-58.3%)
$1.78 M(-42.6%)
Sep 2020
-
$3.10 M(-27.3%)
Jun 2020
-
$4.26 M(+25.1%)
Mar 2020
-
$3.41 M(-20.1%)
Dec 2019
$4.27 M(+2.3%)
$4.27 M(+27.7%)
Sep 2019
-
$3.34 M(-21.7%)
Jun 2019
-
$4.27 M(+6.4%)
Mar 2019
-
$4.01 M(-3.7%)
Dec 2018
$4.17 M(+42.9%)
$4.17 M(+20.6%)
Sep 2018
-
$3.46 M(-33.1%)
Jun 2018
-
$5.16 M(+121.5%)
Mar 2018
-
$2.33 M(-20.1%)
Dec 2017
$2.92 M(+35.7%)
$2.92 M(+66.8%)
Sep 2017
-
$1.75 M(-7.6%)
Jun 2017
-
$1.89 M(-30.2%)
Mar 2017
-
$2.71 M(+26.2%)
Dec 2016
$2.15 M(+332.0%)
$2.15 M(+25.8%)
Sep 2016
-
$1.71 M(-59.0%)
Jun 2016
-
$4.17 M(+176.4%)
Mar 2016
-
$1.51 M(+203.3%)
Dec 2015
$497.80 K(-36.7%)
$497.80 K(+21.8%)
Sep 2015
-
$408.80 K(-17.9%)
Jun 2015
-
$498.00 K(-49.0%)
Mar 2015
-
$977.20 K(+30.3%)
Dec 2014
$787.00 K(+17.3%)
-
Sep 2014
-
$750.00 K(+36.9%)
Jun 2014
-
$547.70 K(-18.4%)
Mar 2014
$671.00 K(-72.4%)
$671.00 K(-60.7%)
Dec 2013
-
$1.71 M(-26.9%)
Sep 2013
-
$2.34 M(+12.4%)
Jun 2013
-
$2.08 M(-14.5%)
Mar 2013
$2.43 M(+20.3%)
$2.43 M(+25.3%)
Dec 2012
-
$1.94 M(+5.3%)
Sep 2012
-
$1.84 M(+1.5%)
Jun 2012
-
$1.82 M(-10.1%)
Mar 2012
$2.02 M(+60.0%)
$2.02 M(+17.1%)
Dec 2011
-
$1.73 M(+5.9%)
Sep 2011
-
$1.63 M(+28.8%)
Jun 2011
-
$1.27 M(+0.2%)
Mar 2011
$1.26 M(-19.0%)
$1.26 M(+0.7%)
Dec 2010
-
$1.25 M(-29.7%)
Sep 2010
-
$1.78 M(+8.3%)
Jun 2010
-
$1.65 M(+5.5%)
Mar 2010
$1.56 M
$1.56 M(-11.4%)
Dec 2009
-
$1.76 M(+8.2%)
Sep 2009
-
$1.63 M(+23.6%)
DateAnnualQuarterly
Jun 2009
-
$1.32 M(+480.2%)
Mar 2009
-
$227.00 K(+216.2%)
Dec 2008
$71.80 K(>+9900.0%)
$71.80 K(+46.5%)
Sep 2008
-
$49.00 K(+113.0%)
Jun 2008
-
$23.00 K(-58.2%)
Mar 2008
-
$55.00 K(>+9900.0%)
Dec 2007
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2007
-
$16.00 K(+23.1%)
Jun 2007
-
$13.00 K(-71.1%)
Mar 2007
-
$45.00 K(-74.3%)
Dec 2006
$174.80 K(-90.0%)
$174.80 K(-87.3%)
Sep 2006
-
$1.37 M(-15.0%)
Jun 2006
-
$1.62 M(-0.8%)
Mar 2006
-
$1.63 M(-6.6%)
Dec 2005
$1.74 M(+3.1%)
$1.74 M(-2.1%)
Sep 2005
-
$1.78 M(+25.8%)
Jun 2005
-
$1.42 M(+0.8%)
Mar 2005
-
$1.41 M(-17.0%)
Dec 2004
$1.69 M(-11.3%)
$1.69 M(-7.6%)
Sep 2004
-
$1.83 M(+1.7%)
Jun 2004
-
$1.80 M(-8.8%)
Mar 2004
-
$1.97 M(+3.4%)
Dec 2003
$1.91 M(-4.8%)
$1.91 M(+40.3%)
Sep 2003
-
$1.36 M(-5.4%)
Jun 2003
-
$1.44 M(+22.1%)
Mar 2003
-
$1.18 M(-41.3%)
Dec 2002
$2.00 M(+5.9%)
$2.00 M(+86.9%)
Sep 2002
-
$1.07 M(-5.0%)
Jun 2002
-
$1.13 M(-11.9%)
Mar 2002
-
$1.28 M(-32.3%)
Dec 2001
$1.89 M(+31.2%)
$1.89 M(+136.4%)
Sep 2001
-
$801.00 K(+15.1%)
Jun 2001
-
$696.00 K(-48.1%)
Mar 2001
-
$1.34 M(-7.0%)
Dec 2000
$1.44 M(+203.8%)
$1.44 M(+174.9%)
Sep 2000
-
$525.00 K(+14.6%)
Jun 2000
-
$458.00 K(-8.4%)
Mar 2000
-
$500.00 K(+5.3%)
Dec 1999
$475.00 K(-70.3%)
$475.00 K(-5.0%)
Sep 1999
-
$500.00 K(-28.6%)
Jun 1999
-
$700.00 K(-12.5%)
Mar 1999
-
$800.00 K(-50.0%)
Dec 1998
$1.60 M(+128.6%)
$1.60 M(+300.0%)
Sep 1998
-
$400.00 K(+33.3%)
Jun 1998
-
$300.00 K(-25.0%)
Mar 1998
-
$400.00 K(-42.9%)
Dec 1997
$700.00 K(+133.3%)
$700.00 K(+250.0%)
Sep 1997
-
$200.00 K(+100.0%)
Jun 1997
-
$100.00 K(-50.0%)
Mar 1997
-
$200.00 K(-33.3%)
Dec 1996
$300.00 K(+50.0%)
$300.00 K(+200.0%)
Sep 1996
-
$100.00 K(-50.0%)
Jun 1996
-
$200.00 K(+100.0%)
Mar 1996
-
$100.00 K(-50.0%)
Dec 1995
$200.00 K
$200.00 K(+100.0%)
Sep 1995
-
$100.00 K(-80.0%)
Jun 1995
-
$500.00 K

FAQ

  • What is Adamis Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for Adamis Pharmaceuticals?
  • What is Adamis Pharmaceuticals annual accounts payable year-on-year change?
  • What is Adamis Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Adamis Pharmaceuticals?
  • What is Adamis Pharmaceuticals quarterly accounts payable year-on-year change?

What is Adamis Pharmaceuticals annual accounts payable?

The current annual accounts payable of ADMP is $7.94 M

What is the all time high annual accounts payable for Adamis Pharmaceuticals?

Adamis Pharmaceuticals all-time high annual accounts payable is $7.94 M

What is Adamis Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, ADMP annual accounts payable has changed by +$4.18 M (+111.44%)

What is Adamis Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of ADMP is $11.37 M

What is the all time high quarterly accounts payable for Adamis Pharmaceuticals?

Adamis Pharmaceuticals all-time high quarterly accounts payable is $11.37 M

What is Adamis Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, ADMP quarterly accounts payable has changed by +$6.85 M (+151.64%)